Marketing Authorisation Holders (MAHs) have informed the VMD of supply problems with the following lactating cow intramammary antibiotics.
|Product||Anticipated Resolution Date (subject to change)|
|Synulox Lactating Cow Intramammary Suspension (42058/4143) Further information||May/June 2020|
|Tetra-Delta Intramammary Suspension (42058/4152)||May/June 2020|
|Ubro Yellow Milking Cow Intramammary Suspension (08327/4305)||Product discontinued – no return date|
|Multiject IMM Intramammary Suspension (02000/4062)||May 2020|
|Albiotic 330mg/100mg Intramammary Solution (30282/4035)||End of February 2020|
|Mastiplan LC, 300mg/20mg Intramammary Suspension (01708/4534)||End of June 2020|
|Cobactan MC Intramammary Suspension for Lactating Cows (42810/4000)*||End of June 2020|
Note: * These are defined as a Highest Priority Critically Important Antibiotics for human medicine and, under the Red Tractor farm assurance scheme for beef and dairy, should be used as a last resort and supported by sensitivity and/or diagnostic testing.
The VMD supports and encourages the responsible use of antibiotics. This however, requires veterinary surgeons to take into consideration, not only the most appropriate active substance(s) but also the most appropriate formulation, the posology, the current pattern of resistance in their locality, an awareness of how to reduce selection pressure (considering MICs and clinical breakpoints when available) and adjunctive requirements (such as good biosecurity and husbandry/hygiene, avoiding surgical sepsis etc). If a veterinary surgeon can demonstrate that these steps have been taken, then cascade use of antibiotics may be considered. Antibiotics should not be used to compensate for poor hygiene or inadequate husbandry and biosecurity measures.?